相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A new 68Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging
Donghui Pan et al.
AMINO ACIDS (2014)
18F-FACBC Compared With 11C-Choline PET/CT in Patients With Biochemical Relapse After Radical Prostatectomy: A Prospective Study in 28 Patients
Cristina Nanni et al.
CLINICAL GENITOURINARY CANCER (2014)
Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer
Ali Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Radiation dosimetry and first therapy results with a 124I/131I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy
Christian M. Zechmann et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Anti-3-[18F]FACBC Positron Emission Tomography-Computerized Tomography and 111In-Capromab Pendetide Single Photon Emission Computerized Tomography-Computerized Tomography for Recurrent Prostate Carcinoma: Results of a Prospective Clinical Trial
David M. Schuster et al.
JOURNAL OF UROLOGY (2014)
Localized Prostate Cancer Detection with 18F FACBC PET/CT: Comparison with MR Imaging and Histopathologic Analysis
Baris Turkbey et al.
RADIOLOGY (2014)
Positron Emission Tomography (PET) Imaging of Prostate Cancer with a Gastrin Releasing Peptide Receptor Antagonist - from Mice to Men
Gesche Wieser et al.
THERANOSTICS (2014)
Evaluation of a technetium-99m labeled bombesin homodimer for GRPR imaging in prostate cancer
Zilin Yu et al.
AMINO ACIDS (2013)
11C-Choline PET/CT Scan in Patients With Prostate Cancer Treated With Intermittent ADT A Sequential PET/CT Study
Francesco Ceci et al.
CLINICAL NUCLEAR MEDICINE (2013)
11C-Choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomy
Francesco Ceci et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
11C-Choline PET/CT and PSA kinetics
Paolo Castellucci et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
PSMA as a target for radiolabelled small molecules
Matthias Eder et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
11C-Acetate PET/CT Before Radical Prostatectomy: Nodal Staging and Treatment Failure Prediction
Mohammed Haseebuddin et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
First-in-Man Evaluation of 2 High-Affinity PSMA-Avid Small Molecules for Imaging Prostate Cancer
John A. Barrett et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Preclinical Evaluation of a Novel 111In-Labeled Bombesin Homodimer for Improved Imaging of GRPR-Positive Prostate Cancer
G. Carlucci et al.
MOLECULAR PHARMACEUTICS (2013)
Monitoring the Clinical Outcomes in Advanced Prostate Cancer: What Imaging Modalities and Other Markers Are Reliable?
Michael J. Morris et al.
SEMINARS IN ONCOLOGY (2013)
PET of Tumors Expressing Gastrin-Releasing Peptide Receptor with an 18F-Labeled Bombesin Analog
Ingrid Dijkgraaf et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-DCFBC, a Low-Molecular-Weight Inhibitor of Prostate-Specific Membrane Antigen, in Patients with Metastatic Prostate Cancer
Steve Y. Cho et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Bombesin analogues for gastrin-releasing peptide receptor imaging
Prasant K. Nanda et al.
NUCLEAR MEDICINE AND BIOLOGY (2012)
Prospects in radionuclide imaging of prostate cancer
Susanne Lutje et al.
PROSTATE (2012)
Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of human prostate cancer xenografts
Rogier P. J. Schroeder et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
123I-MIP-1072, a Small-Molecule Inhibitor of Prostate-Specific Membrane Antigen, Is Effective at Monitoring Tumor Response to Taxane Therapy
Shawn M. Hillier et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Bombesin Antagonist-Based Radioligands for Translational Nuclear Imaging of Gastrin-Releasing Peptide Receptor-Positive Tumors
Keelara Abiraj et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
89Zr-DFO-J591 for ImmunoPET of Prostate-Specific Membrane Antigen Expression In Vivo
Jason P. Holland et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine
Maria J. W. D. Vosjan et al.
NATURE PROTOCOLS (2010)
Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers
Michael C. Haffner et al.
HUMAN PATHOLOGY (2009)
Standardized methods for the production of high specific-activity zirconium-89
Jason P. Holland et al.
NUCLEAR MEDICINE AND BIOLOGY (2009)
Antibody mass escalation study in patients with castration-resistant prostate cancer using 111In-J591:: Lesion detectability and dosimetric projections for 90Y Radioimmunotherapy
Neeta Pandit-Taskar et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Biodistribution and radiation dosimetry of the synthetic nonmetabolized amino acid analogue Anti-18F-FACBC in humans
Jonathon A. Nye et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Phase I evaluation of J591 as a vascular targeting agent in progressive solid tumors
Michael J. Morris et al.
CLINICAL CANCER RESEARCH (2007)
Pilot trial of unlabeled and indium-111-labeled anti-prostate-specific membrane antigen antibody J591 for castrate metastatic prostate cancer
MJ Morris et al.
CLINICAL CANCER RESEARCH (2005)
Phase I trial of yttrium-90-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for androgen-independent prostate cancer
MI Milowsky et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Targeting metastatic prostate cancer with radiolabeled monoclonal antibody J591 to the extracellular domain of prostate specific membrane antigen
NH Bander et al.
JOURNAL OF UROLOGY (2003)
Targeted systemic therapy of prostate cancer with a monoclonal antibody to prostate-specific membrane antigen
NH Bander et al.
SEMINARS IN ONCOLOGY (2003)
Clinical use of monoclonal antibody HuJ591 therapy: Targeting prostate specific membrane antigen
DM Nanus et al.
JOURNAL OF UROLOGY (2003)
Red marrow dosimetry for radiolabeled antibodies that bind to marrow, bone, or blood components
G Sgouros et al.
MEDICAL PHYSICS (2000)
分享论文
